SCHEMBL7614835

SCHEMBL7614835

CCOC(CN1C(=O)/C(=N\OC)c2ccccc21)OCC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.45
MEN1 O00255 1/20 0.45
ALDH1A1 P00352 14/20 0.42
LMNA P02545 2/20 0.42
MAPT P10636 10/20 0.42
KDM4E B2RXH2 3/20 0.42
PKM P14618 2/20 0.42
POLB P06746 1/20 0.42
NPSR1 Q6W5P4 3/20 0.41
CA12 O43570 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
HTT P42858 2/20 0.39
TP53 P04637 1/20 0.39
GAA P10253 1/20 0.38
HPGD P15428 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
TTR P02766 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7614839 1.00 KMT2A (0.45) KMT2AMEN1ALDH1A1LMNAMAPT
SCHEMBL6599293 0.86 ALDH1A1 (0.43) KMT2AMEN1ALDH1A1LMNAMAPT
SCHEMBL6599294 0.86 ALDH1A1 (0.43) KMT2AMEN1ALDH1A1LMNAMAPT
SCHEMBL7615847 0.84 KMT2A (0.49) KMT2AMEN1ALDH1A1LMNAMAPT
SCHEMBL7615845 0.84 KMT2A (0.49) KMT2AMEN1ALDH1A1LMNAMAPT
SCHEMBL7612012 0.81 CES1 (0.56) KMT2AMEN1ALDH1A1
SCHEMBL563821 0.76 KMT2A (0.47) KMT2AALDH1A1PKMHPGDTSHR
SCHEMBL29281824 0.74 ALDH1A1 (0.46) KMT2AMEN1ALDH1A1LMNAMAPT
SCHEMBL29281827 0.74 ALDH1A1 (0.46) KMT2AMEN1ALDH1A1LMNAMAPT
SCHEMBL29281820 0.72 BCHE (0.49) KMT2AALDH1A1LMNAMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0685463-B1 INDOLIN-2-ONE DERIVATIVE CHUGAI PHARMACEUTICAL CO LTD (JP) 2002-05-22 EP disclosed
US-6207836-B1 Indolin-2-one derivatives CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2001-03-27 US disclosed
US-6127544-A 1-SUBSTITUTED-3-UREIDO-INDOLIN-2-ONES WHICH EXHIBIT SELECTIVE ANTAGONISM AGAINST GASTRIN RECEPTORS WITHOUT CAUSING SIDE EFFECTS ATTRIBUTED TO CCK-A RECEPTOR ANTAGONISM; SUCH AS FOR TREATMENT OF PEPTIC ULCERS, GASTRITIS CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2000-10-03 US disclosed
US-6114536-A ANTAGONISM AGAINST GASTRIN RECEPTORS WITHOUT CAUSING SIDE EFFECTS ATTRIBUTED TO CCK-A RECEPTOR ANTAGONISM AND ARE USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES OF DIGESTIVE ORGANS, SUCH AS PEPTIC ULCER, GASTRITIS CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2000-09-05 US disclosed
US-6031111-A Indolin-2-one derivatives CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2000-02-29 US disclosed
US-5952511-A EXHIBITS SELECTIVE ANTAGONISM AGAINST GASTRIN RECEPTOR WITHOUT CAUSING SIDE EFFECTS ATTRIBUTED TO GASTRIN RECEPTOR ANTAGONISM AND USEFUL FOR TREATING PEPTIC ULCER, GASTRITIS, REFLUX ESOPHAGITIS AND ZOLLINGER-ELLISON SYNDROME CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 1999-09-14 US disclosed
EP-0685463-A1 INDOLIN-2-ONE DERIVATIVE CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 1995-12-06 EP disclosed